8 matches for your search in the start-up spotlight

rss
matching the following criteria

image description
Fusix Biotech GmbH

We are a spin-out from the Technical University of Munich, specialising in the clinical and commercial development of a proprietary oncolytic virus platform for cancer immunotherapy. Fusix Biotech GmbH is a Munich based start-up founded in 2022. The management team is comprised of the four ...

more

image description
2NA FISH

2NA FISH is developing a platform technology to measure RNA biomarkers in spatial context, to assist in selecting appropriate cancer therapies and avoid unsuccessful treatments, side effects, reduced survival time, and high costs. Also available as R&D assay kit.

more

image description
IGUANA BIOTECHNOLOGY GmbH

Iguana Biotechnology GmbH (Iguana), an innovative BioTech start-up based in Munich, Germany, is pursuing as a lead candidate the development of a therapeutic vaccine against Helicobacter pylori, one of the most common infectious diseases worldwide. Currently, around 50% of the world's population ...

more

image description
AATec Medical GmbH

AATec Medical GmbH is a biotechnology company developing a product platform based on recombinant alpha-1 antitrypsin (AAT) for the treatment of inflammatory diseases, virus infections and rare diseases. The company has successfully demonstrated proof-of-principle in several indications and is ...

more

image description
mbiomics GmbH

mbiomics is a pioneer in targeted microbiome profiling. Our patented precision technology enables unparalleled quantitative resolution and drastically faster microbiome analysis. This creates a basis for various future clinical applications and it will accelerate microbiome-based therapeutics ...

more

image description
Happy Ocean Foods GmbH

We prefer to enjoy the sea on the beach than on our plates. Our purely plant-based Happy Ocean prawns are not only delicious, but also healthy: for you and our oceans. Happy Ocean Foods was founded in 2020 by Julian Hallet and Robin Drummond. As passionate surfers who care about the ecological ...

more

image description
Tubulis GmbH

Tubulis generates uniquely matched antibody-drug conjugates (ADCs) through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of protein-drug conjugates by increasing design flexibility while overcoming ...

more

image description
NEUREVO GmbH

NEUREVO is developing and will licence first-in-class neuroprotective treatments that effectively protect against multiple neurological disorders. This includes neurodegenerative diseases like ALS or Parkinson's disease and stroke. Our technology is based on the protection and enhancement of ...

more

Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE